NO873571D0 - Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat. - Google Patents

Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.

Info

Publication number
NO873571D0
NO873571D0 NO873571A NO873571A NO873571D0 NO 873571 D0 NO873571 D0 NO 873571D0 NO 873571 A NO873571 A NO 873571A NO 873571 A NO873571 A NO 873571A NO 873571 D0 NO873571 D0 NO 873571D0
Authority
NO
Norway
Prior art keywords
preparation
procedure
therapeutic effective
therapeutic
effective preparation
Prior art date
Application number
NO873571A
Other languages
English (en)
Other versions
NO873571L (no
Inventor
Yukifumi Noda
Hiroyuki Nabata
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO873571D0 publication Critical patent/NO873571D0/no
Publication of NO873571L publication Critical patent/NO873571L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO873571A 1986-08-27 1987-08-24 Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat. NO873571L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP19879686 1986-08-27

Publications (2)

Publication Number Publication Date
NO873571D0 true NO873571D0 (no) 1987-08-24
NO873571L NO873571L (no) 1988-02-29

Family

ID=16397046

Family Applications (1)

Application Number Title Priority Date Filing Date
NO873571A NO873571L (no) 1986-08-27 1987-08-24 Fremgangsmaate for fremstilling av et terapeutisk virksomtpreparat.

Country Status (22)

Country Link
US (1) US4870090A (no)
JP (1) JPH07121863B2 (no)
KR (1) KR950002151B1 (no)
AU (1) AU603375B2 (no)
BE (1) BE1003959A5 (no)
CA (1) CA1302888C (no)
CH (1) CH672069A5 (no)
DE (1) DE3728499A1 (no)
DK (1) DK171392B1 (no)
FI (1) FI873727A (no)
FR (1) FR2605222B1 (no)
GB (1) GB2195532B (no)
HK (1) HK64993A (no)
IE (1) IE60601B1 (no)
IT (1) IT1211477B (no)
LU (1) LU86973A1 (no)
NL (1) NL8701994A (no)
NO (1) NO873571L (no)
NZ (1) NZ221564A (no)
SE (1) SE502323C2 (no)
SG (1) SG52393G (no)
ZA (1) ZA876401B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
AU1363699A (en) * 1997-10-23 1999-05-10 National Institute Of Health Methods for reducing ischemic injury of the heart via the sequential administ ration of monophosphoryl lipid a and adenosine receptor agents
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
CN107773545A (zh) 2016-08-29 2018-03-09 烟台益诺依生物医药科技有限公司 依达拉奉与(+)‑2‑莰醇的舌下用药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
GB1562962A (en) * 1976-04-02 1980-03-19 Chugai Pharmaceutical Co Ltd Nicotinamide derivatives processes for producting the same and pharmaceutical compositions containing the same
WO1986006960A2 (en) * 1985-05-22 1986-12-04 Beecham Group P.L.C. Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
US4696934A (en) * 1986-01-10 1987-09-29 Warner-Lambert Company Method for using nifedipine for treating stroke
WO1987005508A1 (en) * 1986-03-14 1987-09-24 Medical College Of Wisconsin Research Foundation, Method of treatment and prevention of cerebral vasospasms

Also Published As

Publication number Publication date
IE872218L (en) 1988-02-27
CA1302888C (en) 1992-06-09
LU86973A1 (fr) 1987-12-16
BE1003959A5 (fr) 1992-07-22
DK441987D0 (da) 1987-08-25
GB2195532B (en) 1990-05-23
SE8703308L (sv) 1988-02-28
SG52393G (en) 1993-08-06
NZ221564A (en) 1999-08-30
JPS63152317A (ja) 1988-06-24
GB8720219D0 (en) 1987-10-07
HK64993A (en) 1993-07-16
NL8701994A (nl) 1988-03-16
FR2605222B1 (fr) 1991-02-22
JPH07121863B2 (ja) 1995-12-25
KR950002151B1 (ko) 1995-03-14
KR880002525A (ko) 1988-05-09
US4870090A (en) 1989-09-26
IT1211477B (it) 1989-11-03
IT8767725A0 (it) 1987-08-21
FI873727A (fi) 1988-02-28
DK171392B1 (da) 1996-10-14
CH672069A5 (no) 1989-10-31
FI873727A0 (fi) 1987-08-27
GB2195532A (en) 1988-04-13
DE3728499A1 (de) 1988-03-03
NO873571L (no) 1988-02-29
AU7731187A (en) 1988-03-03
DK441987A (da) 1988-02-28
AU603375B2 (en) 1990-11-15
SE502323C2 (sv) 1995-10-02
ZA876401B (en) 1988-04-27
FR2605222A1 (fr) 1988-04-22
SE8703308D0 (sv) 1987-08-26
IE60601B1 (en) 1994-07-27

Similar Documents

Publication Publication Date Title
NO871267D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser.
NO910828L (no) Preparat for behandling av erektil funksjonssvikt.
NO871790L (no) Fremgangsmaate for fremstilling av et oralt farmasoeytisk preparat.
NO875082L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridinoksimer.
NO884052D0 (no) Fremgangsmaate for fremstilling av et terapeutisk preparat.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO167797C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt nitrometan.
NO890155L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser.
NO870866L (no) Fremgangsmÿte for fremstilling av et terapeutisk kombinasjonspreparat.
NO880667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO865028D0 (no) Fremgangsmaate for fremstilling av et terapeutisk system.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO885002L (no) Fremgangsmaate for fremstilling av sialocylglycerolipider.
NO882730D0 (no) Fremgangsmaate for fremstilling av aminocyklopentyletere.
NO894423D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive propanolaminer.
NO873571D0 (no) Fremgangsmaate for fremstilling av et terapeutisk virksomt preparat.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
NO882282L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO880834L (no) Fremgangsmaate for fremstilling av heterocyclyl-2-propyn-1-aminer.
NO863225L (no) Analogifremgangsmaate for fremstilling av et terapeutisk virksomt benzodioxepan.
NO870151L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2-pyrimidinamider.